Can-Fite BioPharma CANF
NYSE CANF
$3.33 -0.02 (-0.60%)
At close: Aug 21, 2026 · 4:00 PM EDT

Can-Fite BioPharma (CANF) Pension (2013 - 2016)

Can-Fite BioPharma's (CANF) quarterly Pension came in at $174000.0 in Q3 2016, up 228.3% YoY from $53000.0 in Q4 2015, and up 4.19% on a QoQ basis from $167000.0 in Q2 2016.

Can-Fite BioPharma (CANF) Pension (2013 - 2016) Analysis & Trends

Can-Fite BioPharma (CANF) has 4 years of Pension data on file, last reported at $174000.0 in Q3 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Can-Fite BioPharma 2.76 Mn -8.79 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2016 174,000.00
Jun 30, 2016 167,000.00
Mar 31, 2016 169,000.00
Sep 30, 2015 53,000.00
Jun 30, 2015 57,000.00
Mar 31, 2015 55,000.00
Sep 30, 2014 36,000.00
Jun 30, 2014 36,000.00
Mar 31, 2014 37,000.00
Sep 30, 2013 19,000.00
Jun 30, 2013 18,000.00